ArticlePathology oncology research : POR2021

The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.

Hui Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.